APDW2024

Background Introduction
From November 21 to 24, 2024, the Asian Pacific Digestive Week (APDW) was held at the Nusa Dua Convention Center in Bali.
Since 2001, APDW has hosted more than 20 successful meetings. The conference is managed by the Steering Committee, which consists of members from the four founding Asia-Pacific associations: APSDE (Asian Pacific Society of Digestive Endoscopy), APASL (Asian Pacific Association for the Study of the Liver), APAGE(Asian Pacific Association of Gastroenterology), and ISDS-AP (International Society of Digestive Surgery - Asia Pacific). These four medical organizations arededicated to jointly promoting and organizing the annual scientific conference,discussing various aspects of digestive system diseases.
This year, in addition to comprehensive solutions for traditional ERCP(Endoscopic Retrograde Cholangiopancreatography), ESD (Endoscopic Submucosal Dissection), and EMR (Endoscopic Mucosal Resection), LeoMed made its debut at the 2024 APDW with its flagship new product, ALL IN ONE.

Exciting Moments
During the exhibition, LeoMed's boothwas bustling with activity, attracting a steady stream of visitors. Medicalexperts, scholars, and industry professionals from various countries andregions gathered around, eager to learn more about the features and functionaladvantages of ALL IN ONE. LeoMed’s staff were busy yet efficient, warmlywelcoming visitors and patiently addressing their professional inquiries.Enthusiastic discussions and exchanges took place, with visitors engaging indeep conversations about the product’s innovation and potential. The atmospherewas vibrant and dynamic, highlighting the product’s appeal and generatingsignificant interest among the attendees.
Some professional attendees showedstrong interest in the exhibits, occasionally taking photos or requestinginformation. Industry leaders even engaged in in-depth discussions withLeoMed's technical experts, creating a very harmonious atmosphere.

The single-use snare Probe (ALL IN ONE) is an innovative medical device tailored for the treatment of early gastrointestinal cancers. It integrates five key functions: marking,dissection, supplementary injection, snaring, and argon plasma coagulation.This product significantly optimizes the surgical process by reducing the frequency of instrument exchanges during the procedure, drastically shortening operation time, and effectively lowering the economic burden on patients. It holds promising market potential. During its debut at the APDW, ALL IN ONE attracted numerous medical experts, and LeoMed's booth was bustling with activity, becoming one of the focal points of the conference.

 

Moving Forward
LeoMed remains committed to innovation as its core driving force, adhering to a strategic direction of"cross-departmental and multi-therapy fields" while continuously deepening the layout of its four key technological platforms: stents, balloons,active devices, and visual technologies. The company maintains a close alignment with cutting-edge industry knowledge and technologies, actively exploring the international field of digestive endoscopy, and driving the continuous optimization and technological advancement of procedures such as ERCP, ESD, and EMR, demonstrating strong innovation capabilities and development potential.